Tata Consultancy Services (TCS) has released a new version of the Connected Clinical Trials (CCT) platform at the recently concluded TCS ADD Vantage forum in Paris.
CCT is an innovative software-as-a-service (SaaS) platform that enables life sciences companies to significantly transform patient engagement in clinical trials and improve the efficiency and accountability of the clinical supply process. CCT is part of TCS' Advanced Drug Development (ADD) suite that offers a wide range of cloud based clinical solutions and services, including clinical data management, metadata management, pharmacovigilance, and data analytics and insights.
TCS is an IT services, consulting and business solutions provider that has been partnering with the world’s largest businesses in their transformation journeys for the last fifty years.
| Company Name | CMP |
|---|---|
| TCS | 2578.45 |
| Infosys | 1311.95 |
| HCL Tech. | 1428.35 |
| Wipro | 202.40 |
| Tech Mahindra | 1504.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: